ベータ-アレスティン-2シグナル複合体の欠乏は,インスリン抵抗性の発生に寄与する
Bing Luan1, Jian Zhao, Haiya Wu
1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, and Graduate School of the Chinese Academy of Sciences.
Nature
|January 6, 2009
まとめ
ベータアレスティン-2欠乏症は,2型糖尿病におけるインスリン抵抗性を悪化させる. ベータアレスティン-2レベルを回復すると,インスリン感受性が改善され,この代謝障害に対する新しい治療標的が提供されます.
科学分野:
- 分子生物学は分子生物学である.
- エンドクリノロジー エンドクリノロジー
- 細胞シグナリング
背景:
- インスリン抵抗性は2型糖尿病の重要な特徴であり,インスリン受容体のシグナリングを損なう.
- フォスファディチルイノシトール-3-OHキナーゼ (PI(3) K) -Akt経路は,インスリンの代謝作用を媒介するために重要である.
- ベータアレスティンは,Gタンパク質結合受容体のシグナル伝達特異性のレギュレータとして知られています.
研究 の 目的:
- インスリン抵抗性および2型糖尿病におけるβ-アレスティン-2の役割を調査する.
- ベータアレスティン2がインスリンシグナル伝達に影響を与える分子メカニズムを解明する.
- インスリン抵抗性の潜在的な治療標的を特定する.
主な方法:
- Beta-arrestin-2のレベルと機能を研究するために糖尿病のマウスモデルを使用しました.
- ベータアレスティン-2のインスリン感受性への影響を評価するために,ノックダウンと投与実験を行った.
- ベータ-アレスティン-2シグナル伝達複合体の形成をインスリン受容体,Akt,Src.と研究した.
主要な成果:
- ベータアレスティン-2は,糖尿病のマウスモデルでダウンレギュレーションされていることが判明しました.
- ベータアレスティン-2のノックダウンにより,インスリン抵抗性が悪化し,投与するとインスリン感受性が改善した.
- インスリン刺激は,AktとSrcをインスリン受容体に支えるベータ-アレスティン-2複合体を促進します.
結論:
- ベータアレスティン-2の喪失または機能障害は,インスリンシグナル伝達を妨害し,インスリン抵抗性および2型糖尿病の進行に寄与します.
- ベータアレスティン-2は,インスリン感受性の維持に重要な役割を果たします.
- 研究結果は,ベータアレスティン-2が,インスリン抵抗性および2型糖尿病の予防と治療のための新しい標的であることを示唆しています.
関連する概念動画
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:30The Electron Transport Chain
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...